calendar

3 catalysts · 2 phase 2 completion · 1 phase 0 trial completion

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

hide past →

sort

soonest latest type sponsor alpha

matching 'Oncology'×TA: cardiology×TA: womens-health×clear all

type

phase 2 completion2
phase 0 trial completion1

therapy area

Oncology148
Infectious Disease4
Cardiology2
Dermatology

Pulmonology1

Women's Health1

Week of Apr 27, 2026

›Apr 30, 2026phase 0 trial completion130d agoSecond Affiliated Hospital of Anhui Medical University — yingtao shujie paste (Phase 0 Trial Completion)yingtao shujie paste

Therapy area: Oncology, Women's Health. Indication: Breast Cancer, Breast Hyperplasia

full page →yingtao shujie paste →source: globaldata

›Apr 30, 2026phase 2 completion130d agoCancer Institute and Hospital Chinese Academy of Medical Sciences — lenvatinib (Phase II Trial Completion)lenvatinib

Therapy area: Cardiovascular, Oncology. Indication: Hepatocellular Carcinoma, Thrombosis, Venous (Vein) Thrombosis

full page →lenvatinib →source: globaldata

›Apr 30, 2026phase 2 completion130d agoMedical University of Gdansk — apixaban (Phase II Trial Completion)apixaban ODT

Therapy area: Cardiovascular, Oncology. Indication: Diffuse Large B-Cell Lymphoma, Hematological Tumor, Leukemia, Lymphoma, Multiple Myeloma (Kahler Disease), Myeloproliferative Disorders, Pulmonary Embolism, Thromboembolic Disease, Venous Thromboembolism

full page →apixaban ODT →source: globaldata